The partnership will further develop P4 Diagnostix’s urology testing services to include somatic testing by integrating the Illumina TruSight Oncology 500 cancer panel, according to a Sept. 28 news release from P4 Diagnostix.
Somatic testing will be incorporated with UroSeq, P4 Diagnostix’s current germline testing product.
The testing will launch at P4 Diagnostix’s laboratory in Indianapolis, the release said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
